Skeletal Kinetics, Llc CRANIOSCULPT C, 5CC. Product Number: C-C5CC, UDI: 813845021112 - - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resorbs and is replace Recall

Check Your Product

According to the U.S. Food and Drug Administration (FDA)

Reason for Recall

As stated by FDA

Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.

Recommended Action

Per FDA guidance

On 04/06/2020, the firmed notified affected customers via email and/or facsimile of "URGENT Medical Device Recall" letter. The letter indicated actions to be taken by the customers and Clinical Providers. For affected customers, the firm is requesting that affected customers: (1) review this letter in full, review current inventory, and complete and return the "Acknowledgement and Receipt Form" via email, recall@skeletalkinetics.com; and (2) return unused inventory via Federal Express with reference to Return Material Authorization. If you have further distributed any of the affected devices to other subaccounts, please communicate this recall information immediately and conduct a sub-recall to those accounts. Please request that they immediately cease distribution of the affected devices and promptly return the product to you. Subsequently, contact the firm for instructions on returning the recalled product you receive from your subaccounts. For affected Health Care Providers, the firm is requesting the following: For any patient that may have been implanted with recalled product, we recommend that healthcare providers use judgement regarding patient follow-up. If the patient shows signs of incomplete bone formation or lack of bone formation, delayed union, or nonunion, the appropriate clinical measures should be taken based on the individual patient circumstances. If the patient experienced adequate healing, there is no reason to believe that there would be any additional concerns with the product. Report any adverse health consequences or quality problems experienced with the use of the product to the firm at 972-677-4600. For questions regarding the recall, contact the firm via email at recall@skeletalkinetics.com.